Lista de obras - Kimberly R Kalli - Dominio Público Uruguay

A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102.

artículo científico publicado en 2010

A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes

artículo científico publicado en 2012

APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.

artículo científico publicado en 2013

APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma

artículo científico publicado en 2016

Abstract A07: Homologous recombination mutations and overall survival in high-grade serous, endometrioid, and clear cell ovarian carcinomas

article published in 2016

Abstract B71: Old age and chemotherapy contribute to the selection of PPM1D somatic mosaic mutations in ovarian cancer

article

Abstract PR05: In vivo antitumor activity of the PARP inhibitor niraparib (MK-4827) in homologous recombination deficient and proficient ovarian cancer

Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody

artículo científico publicado en 2014

An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.

scientific article published on June 2008

An integrative approach to assess X-chromosome inactivation using allele-specific expression with applications to epithelial ovarian cancer.

artículo científico publicado en 2017

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

artículo científico publicado en 2013

Assessment of hepatocyte growth factor in ovarian cancer mortality

artículo científico publicado en 2011

Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic

artículo científico publicado en 2015

Biological Characterization of Human Epithelial Ovarian Carcinoma Cells in Primary Culture: The Insulin-like Growth Factor System ⬇️

artículo científico publicado el 1 de febrero de 1998

Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium

artículo científico publicado en 2013

Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes

artículo científico publicado en 2017

Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status

artículo científico publicado en 2014

Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation.

artículo científico publicado en 2013

Detection of circulating tumor cells in high-risk endometrial cancer.

artículo científico publicado en 2015

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

artículo científico publicado en 2017

Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth

scientific article published on 15 October 2013

EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review

artículo científico publicado en 2017

Elevated fibroblast growth factor 23 in women with malignant ovarian tumors

artículo científico publicado en 2005

Elevated levels of phosphorylated fibrinogen-alpha-isoforms and differential expression of other post-translationally modified proteins in the plasma of ovarian cancer patients

artículo científico publicado en 2006

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

artículo científico publicado en 2013

Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel

artículo científico publicado en 2013

Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers

artículo científico publicado en 2007

Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer

artículo científico publicado en 2004

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study

artículo científico publicado en 2014

Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer

artículo científico publicado en 2011

Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights

artículo científico publicado en 2008

Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer

scientific article published on 02 June 2016

Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients

artículo científico publicado en 2018

Folate receptor alpha as a tumor target in epithelial ovarian cancer

artículo científico publicado en 2008

Functional folate receptor alpha is elevated in the blood of ovarian cancer patients

artículo científico publicado en 2009

Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling

artículo científico publicado en 2002

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

artículo científico publicado en 2013

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy

article

Genes associated with bowel metastases in ovarian cancer

scientific article published on 14 June 2019

Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer.

artículo científico publicado en 2018

Genetic analysis of early- versus late-stage ovarian tumors.

artículo científico publicado en 2001

Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer

artículo científico publicado en 2014

Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer

artículo científico publicado en 2018

Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer ⬇️

artículo científico publicado el 27 de febrero de 2011

Heterogeneous role of caspase-8 in fenretinide-induced apoptosis in epithelial ovarian carcinoma cell lines

artículo científico publicado en 2003

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

artículo científico publicado en 2013

IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer

artículo científico publicado en 2017

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

artículo científico publicado en 2013

Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.

artículo científico publicado en 2009

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

artículo científico publicado en 2009

Immunity and Immune Suppression in Human Ovarian Cancer ⬇️

artículo científico publicado el 1 de abril de 2011

In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.

artículo científico publicado en 2006

In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma.

artículo científico publicado en 2016

Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer.

artículo científico publicado en 2017

Inherited determinants of ovarian cancer survival

artículo científico publicado en 2010

Inherited variants in regulatory T cell genes and outcome of ovarian cancer

artículo científico publicado en 2013

Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer

artículo científico publicado en 2014

Intraperitoneal therapy of ovarian cancer using an engineered measles virus.

artículo científico publicado en 2002

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome

artículo científico publicado en 2014

Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.

artículo científico publicado en 2001

MHC Class II Epitope Nesting Modulates Dendritic Cell Function and Improves Generation of Antigen-Specific CD4 Helper T Cells ⬇️

artículo científico publicado el 25 de mayo de 2011

MORAb-003, a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer

artículo científico publicado en 2007

Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome

artículo científico publicado en 2014

Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures

artículo científico publicado en 2016

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

artículo científico publicado en 2018

Nutritional status, CT body composition measures and survival in ovarian cancer ⬇️

artículo científico publicado el 21 de marzo de 2013

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

artículo científico publicado en 2014

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

artículo científico publicado en 2016

PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κB

artículo científico publicado en 2015

Plasma immune analytes in patients with epithelial ovarian cancer

artículo científico publicado en 2015

Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome ⬇️

artículo científico publicado el 2 de mayo de 2011

Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes

artículo científico publicado en 2017

Pregnancy-associated plasma protein-A (PAPP-A) expression and insulin-like growth factor binding protein-4 protease activity in normal and malignant ovarian surface epithelial cells.

artículo científico publicado en 2004

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts

artículo científico publicado en 2017

Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival

artículo científico publicado en 2015

Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer

artículo científico publicado en 2014

Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers

artículo científico publicado en 2016

Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands

artículo científico publicado en 2008

Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer

artículo científico publicado en 2015

Risk of ovarian cancer and inherited variants in relapse-associated genes

artículo científico publicado en 2010

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10

artículo científico publicado en 2013

Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer ⬇️

artículo científico publicado el 1 de septiembre de 2003

Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity

artículo científico publicado en 2006

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers

artículo científico publicado en 2015

Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma.

artículo científico publicado en 2016

T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer

artículo científico publicado en 2006

TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer

artículo científico publicado en 2015

Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

artículo científico publicado en 2020

The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity

artículo científico publicado en 2007

The immune system in the pathogenesis of ovarian cancer

artículo científico publicado el 1 de enero de 2013

The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins

scientific article published on 26 July 2016

The insulin-like growth factor insulin system in epithelial ovarian cancer ⬇️

artículo científico publicado el 1 de mayo de 2003

The molecular origin and taxonomy of mucinous ovarian carcinoma

scientific article published on 02 September 2019

The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer.

artículo científico publicado en 2013

Toward understanding the genetics of regulatory T cells in ovarian cancer

artículo científico publicado en 2013

Transcriptional profiling reveals that several common fragile-site genes are downregulated in ovarian cancer

scientific article published on 01 August 2002

Transcriptomic Characterization of Endometrioid, Clear Cell, and High-Grade Serous Epithelial Ovarian Carcinoma

artículo científico publicado en 2018

Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer

artículo científico publicado en 2014

Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer

artículo científico publicado en 2011

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

artículo científico publicado en 2014

Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer

artículo científico publicado en 2013

Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer

artículo científico publicado en 2010

Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer

artículo científico publicado en 2014

Lista de obras de Kimberly R Kalli

A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102.

A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes

APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.

APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma

Abstract A07: Homologous recombination mutations and overall survival in high-grade serous, endometrioid, and clear cell ovarian carcinomas

Abstract B71: Old age and chemotherapy contribute to the selection of PPM1D somatic mosaic mutations in ovarian cancer

Abstract PR05: In vivo antitumor activity of the PARP inhibitor niraparib (MK-4827) in homologous recombination deficient and proficient ovarian cancer

Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody

An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.

An integrative approach to assess X-chromosome inactivation using allele-specific expression with applications to epithelial ovarian cancer.

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

Assessment of hepatocyte growth factor in ovarian cancer mortality

Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic

Biological Characterization of Human Epithelial Ovarian Carcinoma Cells in Primary Culture: The Insulin-like Growth Factor System ⬇️

Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium

Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes

Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status

Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation.

Detection of circulating tumor cells in high-risk endometrial cancer.

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth

EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review

Elevated fibroblast growth factor 23 in women with malignant ovarian tumors

Elevated levels of phosphorylated fibrinogen-alpha-isoforms and differential expression of other post-translationally modified proteins in the plasma of ovarian cancer patients

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel

Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers

Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study

Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer

Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights

Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer

Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients

Folate receptor alpha as a tumor target in epithelial ovarian cancer

Functional folate receptor alpha is elevated in the blood of ovarian cancer patients

Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy

Genes associated with bowel metastases in ovarian cancer

Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer.

Genetic analysis of early- versus late-stage ovarian tumors.

Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer

Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer

Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer ⬇️

Heterogeneous role of caspase-8 in fenretinide-induced apoptosis in epithelial ovarian carcinoma cell lines

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

Immunity and Immune Suppression in Human Ovarian Cancer ⬇️

In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.

In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma.

Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer.

Inherited determinants of ovarian cancer survival

Inherited variants in regulatory T cell genes and outcome of ovarian cancer

Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer

Intraperitoneal therapy of ovarian cancer using an engineered measles virus.

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome

Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.

MHC Class II Epitope Nesting Modulates Dendritic Cell Function and Improves Generation of Antigen-Specific CD4 Helper T Cells ⬇️

MORAb-003, a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer

Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome

Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

Nutritional status, CT body composition measures and survival in ovarian cancer ⬇️

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κB

Plasma immune analytes in patients with epithelial ovarian cancer

Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome ⬇️

Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes

Pregnancy-associated plasma protein-A (PAPP-A) expression and insulin-like growth factor binding protein-4 protease activity in normal and malignant ovarian surface epithelial cells.

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts

Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival

Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer

Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers

Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands